Log-rolling champ Shana Verstegen's event to raise funds for Huntington's disease research will once again take place at the Monona Terrace on Feb. 15.

Log-rolling champ Shana Verstegen's event to raise funds for Huntington's disease research will once again take place at the Monona Terrace on Feb. 15.

MMJ is currently engaged in litigation with the Drug Enforcement Administration (DEA). The company contends that the DEA has obstructed domestic cannabis research despite the Right To Try and the ...

Despite the recent launch of congenital adrenal hyperplasia (CAH) drug Crenessity, Neurocrine Biosciences' disappointing ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the global licensing and collaboration agreement with Sarepta Therapeutics (NASDAQ: SRPT) announced on November 26, 2024, has now ...

Needham & Company LLC reiterated their hold rating on shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) in a research report released on Friday,Benzinga reports. Several other equities ...

Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its target price lowered by Royal Bank of Canada from $154.00 to $148.00 in a report released on Friday,Benzinga reports. The brokerage currently ...

Arrowhead Pharmaceuticals, Inc. ( NASDAQ: ARWR) Q1 2025 Earnings Conference Call February 10, 2025 4:30 PM ET Chris Anzalone - President & CEO Bruce Given - Interim Chief Medical Scientist Andy Davis ...

Katy Perry has thrilled the crowd at the opening ceremony of the 2025 Invictus Games in Vancouver, Canada. The pop star showed support for her Montecito neighbours, Prince Harry, who founded the event ...

Toxics in the air from urban wildfires may include dioxins, asbestos, and lead. But testing, until recently, for these air ...

Walgreens is closing three stores in Orange County and another two in Los Angeles County by March. At least 93 people could ...

H.C. Wainwright analyst Andrew Fein adjusted the price target for Neurocrine Biosciences (NASDAQ:NBIX) to $185 from the previous $190 while maintaining a Buy rating on the stock. This revision follows ...